Ritholtz Wealth Management acquires 148 shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Ritholtz Wealth Management raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 4.0% during the second quarter, Holdings Channel reports. The fund owned 3,875 shares of the medical equipment provider’s stock after purchasing an additional 148 shares during the quarter. Ritholtz Wealth Management’s holdings in Intuitive Surgical were worth $1,724,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its holdings in shares of Intuitive Surgical by 1.6% in the first quarter. Vanguard Group Inc. now owns 30,868,620 shares of the medical equipment provider’s stock worth $12,319,358,000 after buying an additional 493,126 shares during the period. Price T Rowe Associates Inc. MD grew its position in shares of Intuitive Surgical by 1.6% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 16,973,266 shares of the medical equipment provider’s stock worth $5,726,102,000 after purchasing an additional 272,741 shares in the last quarter. Capital World Investors grew its position in Intuitive Surgical by 1.0% in the first quarter. Capital World Investors now owns 7,284,269 shares of the medical equipment provider’s stock valued at $2,907,079,000 after buying an additional 73,634 shares during the period. Edgewood Management LLC lifted its position in shares of Intuitive Surgical by 7.9% in the 4th quarter. Edgewood Management LLC now owns 5,131,066 shares of the medical equipment provider’s stock worth $1,731,016,000 after acquiring an additional 374,667 shares during the period. Finally, Jennison Associates LLC boosted its position in Intuitive Surgical by 4.6% in the first quarter. Jennison Associates LLC now owns 4,488,343 shares of the medical equipment provider’s stock valued at $1,791,253,000 after acquiring an additional 198,483 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s shares.

Indoor activity

In other Intuitive Surgical news, Director Craig H. Barratt sold 1,400 shares of Intuitive Surgical stock in a transaction dated Wednesday, June 5th. The shares were sold at an average price of $411.00, for a total transaction of $575,400.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available via this link. In related news, Director Craig H. Barratt sold 1,400 shares of the stock in a transaction dated Wednesday, June 5th. The shares were sold at an average price of $411.00, for a total transaction of $575,400.00. The transaction was disclosed in a filing with the SEC, which is accessible via this hyperlink. Also, EVP Robert Desantis sold 239 shares of the business’s stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $416.60, for a total transaction of $99,567.40. Following the sale, the executive vice president now owns 5,506 shares in the company, valued at $2,293,799.60. The disclosure for this sale can be found here. Insiders sold a total of 53,056 shares of company stock valued at $25,276,044 over the last quarter. Insiders own 0.90% of the company’s shares.

The Wall Street analyst weighs in

A number of analysts recently weighed in on ISRG shares. Truist Financial boosted their target price on shares of Intuitive Surgical from $450.00 to $515.00 and gave the company a “buy” rating in a report on Tuesday, July 16th. Robert W. Baird raised their price target on Intuitive Surgical from $487.00 to $503.00 and gave the company an “outperform” rating in a research report on Friday, July 19th. Stifel Nicolaus raised their target price on shares of Intuitive Surgical from $430.00 to $475.00 and gave the stock a “buy” rating in a research note on Friday, July 19th. Evercore ISI cut their price target on Intuitive Surgical from $425.00 to $410.00 and set an “in-line” rating for the company in a research note on Friday, July 19th. Finally, Redburn Atlantic raised Intuitive Surgical from a “neutral” rating to a “buy” rating and upped their price objective for the company from $380.00 to $510.00 in a report on Friday, August 2. Six analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $446.45.

Read our latest review on intuitive surgery

Intuitive surgical trading up 1.1%

Shares of ISRG stock opened at $492.63 on Monday. The firm has a 50 day moving average of $454.69 and a two hundred day moving average of $414.94. Intuitive Surgical, Inc. has a 12-month low of $254.85 and a 12-month high of $493.97. The company has a market cap of $175.06 billion, a price-to-earnings ratio of 88.92, a PEG ratio of 5.43 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report ) last posted its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, topping the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The company had revenue of $2.01 billion for the quarter, compared to analyst estimates of $1.97 billion. In the same quarter last year, the firm earned $1.18 EPS. The company’s quarterly revenue was up 14.5% compared to the same quarter last year. As a group, equities analysts estimate that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current year.

Intuitive Surgical Company Profile

(Free report)

Intuitive Surgical, Inc develops, manufactures and markets products that enable physicians and healthcare providers to improve the quality and access to minimally invasive care in the United States and internationally. The company offers the da Vinci surgical system that enables complex operations using a minimally invasive approach; and the Ion endoluminal system, which expands its commercial offerings beyond surgical interventions in diagnostic procedures that allow minimally invasive biopsies in the lungs.

Read more

Want to see what other hedge funds hold ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trading for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).

Get news and reviews for Intuitive Surgical Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Intuitive Surgical and related companies with MarketBeat.com ‘s FREE daily email newsletter.